Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BMRN Biomarin Pharmaceutical

Watchlist
112.840
-3.870-3.32%
Close  02/02 16:00 ET
High
116.700
Open
116.640
Turnover
199.69M
Low
111.840
Pre Close
116.710
Volume
1.76M
Market Cap
20.97B
P/E(TTM)
262.42
52wk High
117.770
Shares
185.85M
P/E(Static)
Loss
52wk Low
70.730
Float Cap
20.77B
Bid/Ask %
0.00%
Historical High
151.750
Shs Float
184.07M
Volume Ratio
1.28
Historical Low
3.570
Dividend TTM
--
Div Yield TTM
--
P/B
4.59
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.96%
Amplitude
4.16%
Avg Price
113.560
Lot Size
1
Float Cap
20.77B
Bid/Ask %
0.00%
Historical High
151.750
Shs Float
184.07M
Volume Ratio
1.28
Historical Low
3.570
Dividend TTM
--
P/B
4.59
Dividend LFY
--
Turnover Ratio
0.96%
Amplitude
4.16%
Avg Price
113.560
Lot Size
1
Price Forecast

News

Comment

Company Overview More
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
CEO: Mr. Jean-Jacques Bienaime
Market: NASDAQ
Listing Date: 07/23/1999
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist